Cellectar Biosciences Inc.
CLRB | NASDAQ
$2.35
-$0.03 (-1.26%)
At close: Sep 21, 2026, 4:00 PM ET
$2.35
$0 (0.00%)
After-hours:
Sep 21, 2026, 7:30 PM ET
Market Data
Market Cap $19.02M
Enterprise Value $-13.69M
Beta 0.56
Average Volume 1.07M
Shares Outstanding (Diluted) 12.23M
Shares Change YoY 660.31%
Institutional Ownership 7.33%
Exchange NASDAQ
ISIN US15117F8804
Price Performance
Price Change 1M -10.0%
Price Change 3M -6.0%
Price Change 6M -20.3%
Price Change YTD -32.3%
Price Change 1Y -57.3%
Price Change 3Y -96.9%
Price Change 5Y -99.2%
1M CAGR (ann.) -5.6%
1Y CAGR (ann.) -53.0%
5Y CAGR (ann.) -62.3%
All-Time CAGR -57.9%
Valuation
PE Ratio -0.52
Forward PE N/A
PEG Ratio -0.00
Forward PEG 0.02
PS Ratio N/A
Forward PS 2.50
PB Ratio 0.63
P/FCF Ratio -0.96
P/Adj. FCF Ratio -0.94
P/OCF Ratio -1.48
EV/Sales N/A
EV/EBIT 0.61
EV/EBITDA 0.61
EV/FCF 0.70
Earnings Yield -194.0%
FCF Yield -103.8%
Adj. FCF Yield -106.0%
Financial Health
Net Cash $33.99M
Total Debt $1.53M
Cash & Short-Term Investments $33.99M
Total Assets $36.64M
Current Ratio 6.66
Quick Ratio 6.66
Debt / Equity Ratio 0.05
Debt / EBITDA -0.07
Debt / FCF -0.08
OCF / Debt -12.72
Interest Coverage 0.00
Altman Z-Score -10.12
Piotroski F-Score 3
Margins & Profitability
Gross Profit Margin 0.0%
Operating Profit Margin 0.0%
EBITDA Margin 0.0%
Net Profit Margin 0.0%
FCF Margin N/A
Adj. FCF Margin N/A
SBC / Revenue 0.0%
SBC Impact (per share) -2.2%
Returns
Return on Assets -60.9%
Return on Equity -165.7%
Return on Invested Capital -74.9%
Return on Capital Employed -74.9%
Return on Tangible Assets -60.9%
Historical Growth (CAGR)
Revenue CAGR 3Y N/A
Revenue CAGR 5Y N/A
Revenue CAGR 10Y N/A
EPS CAGR 3Y 111.8%
EPS CAGR 5Y 47.1%
EPS CAGR 10Y 35.1%
FCF CAGR 3Y 39.8%
FCF CAGR 5Y -0.1%
FCF CAGR 10Y -13.1%
Analyst Forecasts
Analyst Rating Buy
Analyst Count 8
EPS Growth Next 3Y 39.2%
Revenue Growth Next 3Y N/A
Earnings Date N/A
EPS Estimate (next Q) N/A
EPS Growth Est (next Q) N/A
Revenue Est (next Q) N/A
Revenue Growth Est (next Q) N/A
Fair Value Estimates
Graham Number N/A
Graham Upside N/A
Lynch Fair Value N/A
Lynch Upside N/A
Price Target $11
Price Target Upside 368.1%
Cash Flow
Operating Cash Flow $-19.47M
Free Cash Flow $-19.48M
Adj. Free Cash Flow $-19.91M
FCF Per Share -$1.59
OCF Per Share -$1.59
OCF/S Ratio 0.0%
Income Statement
Revenue $0
Gross Profit $110.02K
Operating Income $-23.53M
EBITDA $-22.33M
Net Income $-22.32M
EPS (Diluted) -$4.56
Revenue / Employee N/A
Profit / Employee $-2.03M
Employees 11
Add to Watchlist
Select watchlists to add or remove CLRB